Prescription drugs

Medicare Director Meena Seshamani on CMS’ New Drug Pricing Powers

Medicare director Meena Seshamani discusses her team’s sprint to put historic drug price reforms into action.

Read More

Medicare Releases Details of Major Drug Price Reform

Medicare’s historic plan to slow prescription drug spending is taking shape.

Read More

The End of Humira’s $200 Billion Drug Monopoly

What will happen when the best selling drug ever finally faces direct competition?

Read More

‘Three Health Policy Stories to Watch in 2023’ Transcript

In 2023 states will pursue new abortion laws, restart Medicaid eligibility checks and Medicare begins to flex its new power to negotiate drug prices.

Read More

Local Officials Grapple With How to Spend Billions in Opioid Settlement Dollars

More than $50 billion in opioid settlement dollars from drugmakers, distributors and pharmacies are starting to flow to state and local governments.

Read More

Local Officials Grapple With How to Spend Billions in Opioid Settlement Dollars Transcript

‘Local Officials Grapple With How to Spend Opioid Settlement Dollars’ Transcript November 17, 2022   Note: This transcript has been created with a combination of machine ears and human eyes. There may be small differences between this document and the audio version, which is one of many reasons we encourage you to listen to the episode! Listen…

Read More

Medicare’s Prescription Drug Plan Makeover Transcript

‘Medicare’s Prescription Drug Plan Makeover’ Transcript October 27, 2022 Note: This transcript has been created with a combination of machine ears and human eyes. There may be small differences between this document and the audio version, which is one of many reasons we encourage you to listen to the episode! Listen in Apple Podcasts Listen on Spotify…

Read More

Medicare’s Prescription Drug Plan Makeover 

An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.

Read More

The Race to Prepare for Medicare’s New Drug Pricing Powers

Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.

Read More

Dems’ New Drug Pricing Deal: What You Need to Know

Stacie Dusetzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.

Read More